key: cord-0702925-9h07p620
authors: Kemp, Francoise; Proverbio, Daniele; Aalto, Atte; Mombaerts, Laurent; d’Herouel, Aymeric Fouquier; Husch, Andreas; Ley, Christophe; Goncalves, Jorge; Skupin, Alexander; Magni, Stefano
title: Modelling COVID-19 dynamics and potential for herd immunity by vaccination in Austria, Luxembourg and Sweden
date: 2021-08-21
journal: J Theor Biol
DOI: 10.1016/j.jtbi.2021.110874
sha: 564125dbe889b9275b8598b953f62c716650f68c
doc_id: 702925
cord_uid: 9h07p620

Against the COVID-19 pandemic, non-pharmaceutical interventions have been widely applied and vaccinations have taken off. The upcoming question is how the interplay between vaccinations and social measures will shape infections and hospitalizations. Hence, we extend the Susceptible-Exposed-Infectious-Removed (SEIR) model including these elements. We calibrate it to data of Luxembourg, Austria and Sweden until 15th December 2020. Sweden results having the highest fraction of undetected, Luxembourg of infected and all three being far from herd immunity in December. We quantify the level of social interaction, showing that a level around 1/3 of before the pandemic was still required in December to keep the effective reproduction number R eff t below 1, for all three countries. Aiming to vaccinate the whole population within 1 year at constant rate would require on average 1,700 fully vaccinated people/day in Luxembourg, 24,000 in Austria and 28,000 in Sweden, and could lead to herd immunity only by mid summer. Herd immunity might not be reached in 2021 if too slow vaccines rollout speeds are employed. The model thus estimates which vaccination rates are too low to allow reaching herd immunity in 2021, depending on social interaction. Vaccination will considerably, but not immediately, help to curb the infection; thus limiting social interactions remains crucial for the months to come.

In December 2019, a novel strain of coronavirus SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) was first reported in Wuhan, China. In severe cases, it causes an acute respiratory distress syndrome (ARDS), which can lead to respiratory failure, septic shock, multi-organ failure and death [1] . 5 By mid December 2020, worldwide 72 million confirmed cases and 1,6 million dead people had been identified to be infected with SARS-CoV-2.

To help mitigating the coronavirus disease 2019 (COVID-19) pandemic, mathematical modelling has become a major tool in understanding its diffusion [2] . As COVID-19 is currently widely spread across the globe, short-and 10 medium-term modelling forecasts assess the need for containment strategies. For these purposes, one of the most employed models is the Susceptible-Exposed-Infectious-Removed (SEIR) model, for which numerous extensions have been developed recently. Extensions including compartments for hospitals and deaths have been developed among others for Italian regions [3] and Sweden [4] . An ex- 15 tension to investigate the crucial role of asymptomatic cases was developed in [5] .

One including a time-varying transmission rate was presented in [6] for France and Ireland. A network-based version of the SEIR model focused on Italian regions [7] showed that the effects of the employed measures have been decisive in preventing much worst outcomes. An extension including asymptomatic cases 20 showed that the timing of social distancing is crucial [8] . Various synergies of different mitigation strategies can lead to similar suppression of the infection, with different consequences [9] . Models were developed to investigate the effectiveness of specific non-pharmaceutical interventions employed as lockdown-like measures and universal masking [10] or social distancing and travel restrictions 25 [11] . Different measures have different economical consequences, and the epidemiological and economical aspects of the pandemic strongly influence each others [12] .

In this study, we extend the SEIR model including a social interaction parameter, the presence of undetected cases, vaccination and the disease progres- 30 sion through hospitals, ICU, recovery and death. The aim is to understand the different phases of the pandemic which occurred in countries employing different policies, and to investigate how the interplay between vaccination strategies and social interactions might lead towards herd immunity throughout 2021. We focus on the epidemic dynamics of three countries: Luxembourg, having the 35 highest fraction of detected COVID-19 cases per 100,000 inhabitants in Europe in December 2020; Sweden, following different intervention strategies, not imposing a full lockdown and considered having attempted to reach herd immunity early on; Austria, showing dynamics comparable to Luxembourg. We calibrate the model separately to publicly available data of each country, and employ it 40 to compare the epidemic dynamics during infection waves within and between countries.

The model is further used to inquire dynamical trends associated with vaccination. As several vaccines became available at the end of 2020, systematic vaccination campaigns have taken off in a number of countries in the first months 45 of 2021. They are of extreme interest, not only to protect the most vulnerable people, but also to contribute to eradicate the virus in the population through herd immunity [13] . Herd immunity is achieved when a certain fraction of the total population is immune to the infectious disease (through natural infection or vaccination), so that the infectious agent can no longer generate large out-50 breaks [14] . Much remains to be learned about immunity to SARS-CoV-2 [15] , and there exist additional challenges to mass vaccination, associated to supplying of vaccines and the logistic of their deployment. A key question in the current COVID-19 pandemic is thus how and when herd immunity could be achieved [14] . 55 To tackle this question, we use our model to investigate the potential impact of various vaccination strategies and their synergy with social measures for the considered countries. We investigate when herd immunity might be reached depending on vaccines rollout speed in plausible scenarios. The desirable objective would be to achieve herd immunity primarily by mass vaccination, while avoid- 60 ing the saturation of healthcare systems and having as few cases and deaths as possible. In fact, the alternative to achieve herd immunity primary by infection has been shown to pose severe risks of overwhelming the health care system and to lead to high numbers of deaths [16] .

With our study, we are aligned to a long standing tradition of using math- 65 ematical models in the design of mass immunization programs [17] . Recently, some works presented results based on simple models and conceptual scenarios [18, 19, 20, 21] . Attainability of herd immunity by vaccination in the UK is investigated in [22] . Instead, the presented model is calibrated on data from multiple countries and includes compartments for disease progression and un- 70 detected cases, and has the scope to systematically investigate the interplay of vaccination strategies and plausible social interaction scenarios in the pursuit of herd immunity. This model was also employed during the ongoing pandemic to investigate the impact of reductions of social interaction and to generate projections to inform policy-making. 75 

We develop a mathematical model of the transmission of COVID-19 within a country's population, extending the standard Susceptible-Exposed-Infectious-Removed (SEIR) model [23] to include 1) undetected cases; 2) varying social 80 interaction; 3) the progression of severe cases through hospitalization, intensive care and eventually death or recovery and 4) vaccination. The model, Fig. 1 , is implemented through a set of ordinary differential equations (Eqs. A.2 in Appendix). The total population N of the considered country is streamed at time t into 16 compartmental variables, Tab. A.1. An important fraction of in-85 fected people is usually not detected [24] , so we introduce a separation between detected and undetected cases. One branch (detected cases) can lead to quarantine and possibly to hospital and/or ICU. The other (undetected cases, either because they are asymptomatic [5] or simply due to lack of testing) continues spreading the infection until recovery or death. The probability of an infected Mathematical models are necessarily simplifications of reality. They balance complexity, including the factors crucial to answer the investigated questions and to learn useful real-world lessons, with simplicity, as they need to be simple enough to be numerically and/or computationally tractable. Hence, the present model relies on a number of assumptions.

As other SEIR models, the present model is deterministic and mean-field, so it does not describe the stochastic aspects of the epidemic, e.g. superspreading events, but concentrates instead on its average evolution. Alternative 115 approaches to ODE-based models have been developed, e.g. agent-based models [25] , recently applied e.g. in Luxembourg [26] , Switzerland [27] or Australia [28] . Deviations from mean-field effects are expected to play an important role in periods of low infections numbers, where e.g. one or few super-spreading events can make the difference between starting or not a wave of infections [29] . 120 However, with high case numbers we expect a deterministic description to be sufficiently accurate, especially when it comes to the progression of infected individuals into more severe stages as hospitalisation, ICU and death.

The model does not include age structure. As COVID-19 case fatality rate, hospitalization and ICU admission rates vary with age, the values of our pa-125 rameters represent an average over age groups. Instead of capturing the agedependent risk of disease progression, the present model fits and simulates aggregated hospitals and ICUs occupations and deaths. This allows to compare simulated scenarios for the evolution of aggregated quantities under different assumptions, for which age structure is not crucial. Moreover, not consider-130 ing explicitly the age structure reduces the number of parameters to fit, thus improving calibration and reducing fitting uncertainties. In addition, while in principle the effective reproduction number R eff (t) can be derived analytically in age-structured SEIR-like models [30, 31, 32] , the absence of age structure here contributes to make its derivation much more tractable in practice. Nonetheless, 135 the current assumption could lead our estimates to represent a pessimistic case, since previous computational studies have shown that including age-dependent contacts in an agent based model can reduce the threshold for reaching herd immunity [33] .

The other factor contributing to make R eff (t) analytically tractable is the 140 way we implement vaccination. Vaccination is also modelled in a simplified manner, namely as individuals flowing at a constant rate out of the susceptible compartment (see also Appendix D). This implies four assumptions. First, we assume that vaccination proceeds at a constant rate. In reality, the rate depends among other factors on vaccines availability; hence, the vaccination rate in the 145 model is intended as an average, reference value. Second, we use the terms "vaccination" and "vaccinated people" referring to individuals who have been fully vaccinated (not those with half coverage from two-doses vaccines). This should be considered when comparing real numbers to the vaccination rollout speeds employed in this paper. Third, we assume 100% vaccine efficacy in preventing 150 an individual from getting infected, developing symptoms and infecting others. This is an optimistic approximation. Fourth, we assume that only susceptible individuals are vaccinated, while in reality also recovered individuals are. While the number of recovered individuals is in the countries and scenarios investigated here considerably lower than the number of susceptible, to some extent 155 supporting this approximation, removing this assumption would somewhat increase the vaccination rates needed to obtain the same results with respect to our estimates. Overall, these assumptions make our vaccination simulations an optimistic limit. However, the absence of age-structure makes our estimates of the herd immunity threshold a pessimistic limit, so the two effects might 160 compensate to some extent, which is difficult to quantify. The impact of the assumptions mentioned here is discussed in more detail in Sec. 4.

The model is fitted to available public time-series data (from February to 15th December 2020), independently for each wave and country. Detailed For each country and epidemic wave, we initially manually calibrate a set of parameters that allow the simulations to fit the data while incorporating 175 literature knowledge (see Appendix H). In the rest of the paper, we will refer to this parameter set as "manual fit" or "manual calibration". In particular, these parameters are obtained from non-country-specific literature as [34, 35, 36] , or from country-specific literature or data as [37, 38, 39, 40] , or from assumptions. are obtained by best fitting the simulation of new cases to the moving average of 185 the corresponding data. This method already returns good agreement between simulations and data from several time-series data (cf. Fig. 2 ), thus supporting our choice of parameters.

We further cross-validate the calibration of our model by Bayesian inference and Markov Chain Monte Carlo (MCMC) methods (cf. Appendix I). Such 190 methods have been widely applied in the framework of the pandemic to infer epidemiological parameters from SEIR-based or other models, e.g. for Spain [41] , Germany [42] and in a comparison of 11 countries, including Austria and it does not provide a unique parameter set due to poor identifiability, common to SEIR models [44] . In fact, the two parameter sets obtained respectively from the maxima of the posteriors (maximum a posteriori estimate) and from the means of the posteriors are rather different from each other due to asymmetric posteriors. Moreover, certain parameters are poorly constrained by the data, 210 resulting in rather flat posterior probability distributions. For the simulations, we thus employ the manually calibrated parameter set, which is unique, consistent with the results of the MCMC, and incorporates domain knowledge from literature as explained in Appendix H. The model also accounts for undetected cases, through a dedicated compartment flow. In particular, the probability p 1 of being detected is estimated for each country and wave from available prevalence data, see Appendix Tab. H.6.

These undetected cases are reported in panels A, B and C of Fig. 2 as cumu-225 lative numbers. Over time, this number (violet dashed curve) is approximately between one and two times the number of detected cases for Luxembourg and Austria, while it is up to three to four times for Sweden. The percentage of undetected is in all three countries higher than that of detected, which is in line with estimates like [45] . Nevertheless, for Austria and Sweden the sum of 230 detected cases and the estimated number of undetected cases until December remains more than an order of magnitude smaller than the population of the country, while for Luxembourg it is higher. In fact, our model shows that until the 15th December, the percentage of population having been infected by SARS-CoV-2 in Luxembourg is about 18.3% (7.2% detected and 11.1% unde-235 tected); in Austria 9% (3.7% detected and 5.3% undetected) and in Sweden 14.5% (3.5% detected and 11% undetected). For all three countries, this made herd immunity still far from being reached in December 2020.

On top of reproducing the historical development, the model is employed to simulate potential future scenarios of the epidemic in each country. In to no change in social interaction w.r.t. mid December; an optimistic scenario where social interaction becomes as low as during the lockdown in March; a pessimistic scenario where it becomes as high as in October. These three scenarios 245 are meant to represent an average outcome and two extreme, but plausible cases.

While instructive, projections might be accurate for few weeks, but less so on longer time periods as small changes in e.g. social interaction and corresponding parameter can lead to large changes in the simulated outcome. Consequently, their goal is mainly to investigate potential scenarios that might unfold from 250 the current situation [41] and compare them between each other.

The parameter ρ (t) tunes social interactions, and changes when new measures or major behavioural changes occur. It is thus implemented as a piece-wise constant function of time. Its value changes at specific dates t n when modifica- Panels in Fig. 3 show values of ρ n from both manual calibration and Bayesian inference, which are both proportional to daily cases number. Manually cal- 

The social interaction parameter ρ (t) changes a limited number of times to 305 represent changes in non-pharmaceutical interventions or population behaviour.

To fit the first waves of Luxembourg and Austria, all other parameters are constant (though slightly different between the two countries), as the time evolution of daily new cases, hospital and ICU occupation are alike, although scaled and delayed. However, the same parameters from the first wave overestimate the 310 hospital progression during the second wave. The MCMC estimates do not fully reflect the changes in some parameters that we performed between one wave and the next in the manually calibrated parameter set (see Fig. 4 and Appendix Tab. H.6). These discrepancies could 340 indicate that, due to the large uncertainty in parameter identification in our Bayesian inference, multiple parameter sets could provide equally good fit between model and data (see Appendix for further discussion about system identifiability). Supposedly, means provide more robust information than maxima, which are representative of the posterior distribution only when the posterior 345 has a clear peak and is not almost flat. This results in some of the FCs obtained from the maxima (large blue dots) having extreme values, in particular those associated with τ 4 , τ 5 , τ 6 and τ 7 , i.e. the rates involved in the patient progression through hospital and ICU. unlikely to happen for several months consecutively.

Panels A, B and C in Fig. 5 shows that, for high social interaction levels, a smaller number of people will need vaccination, since more people already got infected naturally. Slower vaccination strategies will also result in less people to be vaccinated as more people will by then have acquired immunity naturally.

These observations are consistent across considered countries.

Panels D, E and F report the simultaneous effects of social interaction and shrinking of the pool of susceptible, due to both infection and vaccination, on R eff (t). In each country, for any vaccination strategy as well as for no vaccination, the pessimistic scenario (red) starts with a higher R eff (t) than 380 the "no change" scenario (blue). However, the situation is eventually inverted due to larger shrinking of the susceptible pool associated with higher social

interactions. This suggests that the interplay between social interaction and vaccination is non-trivial; it is deeper investigated in the next section.

Panels G, H and I illustrate the changes in dynamics of total detected cases 385 for the same scenarios and strategies. We observe that the faster the vaccines rollout, the fewer total detected cases are reached asymptotically. Any vaccination strategy considered leads to considerable reduction of the detected cases number w.r.t. no vaccination. This discrepancy is larger than the difference in cases between the three strategies. For all three countries, the number of total 

Expanding what considered above, we tackle the following question: when 400 might herd immunity be reached, depending on combinations of social interaction and vaccination strategies? In mean field SEIR-like models with homogeneous mixing of the individuals, the population fraction needing to be immune, in order to reach herd immunity in the absence of measures is estimated as

. To answer the above question, we compute this quantity 405 for the three countries. Using the values of R 0 previously estimated, we obtain: factors not included in the model might influence these estimates, making herd immunity more difficult or easier to achieve, e.g. reinfections and age structure of the population, discussed at the end of the paper.

As COVID-19 is an ongoing situation, we further estimate the vaccine rollout 

To obtain a reliable dynamical model, we estimated its parameters. Complex epidemiological models might suffer from poor identifiability of their parameters [44] often associated with data quality, quantity and fitting methods. To address this and provide consistent estimates, the parameter set was initially manually calibrated and then cross-validated by Bayesian inference, which elucidates pa- to be introduced within each wave. This does not reflect a rise in infections, but rather a major change in testing strategy and a better prognosis linked to younger patients [53, 54] .

The model also allows to estimate the fraction of undetected cases from prevalence data. Luxembourg and Austria display (see Fig. 2 Once calibrated, the model allows to inspect future scenarios to inform data- After calibration, we extended the model with a vaccination compartment and we quantified how long it would take to reach herd immunity. First, we considered the same scenarios as above (cf. Fig. 5) . The difference between the detected cases curves of the two considered social interaction scenarios is larger 560 than the difference between the different vaccination strategies. This indicates that during the vaccination process, reduced social interactions are still going to be crucial to keep the number of cases under control, to avoid saturation of hospitals and ICUs and to reduce the number of deaths.

Considering herd immunity by vaccination only (Fig. 6) As any modelling effort, the current model comes with limitations. To begin with, it does not include an age structure. Age distribution can influence hospital admission rates and fatality rates, and has been suggested to play a role in lowering the herd immunity fraction potentially down to 30-50% [33, 55, 26 ].

The age distribution should be considered when designing vaccination cam-615 paigns, as literature studies agree that vaccinating the elderly first would reduce the hospital burden and death toll [56, 57, 58] . As a consequence, our model was primarily used to investigate the aggregated dynamics and to project reasonable scenarios with homogeneous interventions in pursuit of overall herd immunity, but it does not cover the design of age-dependent measures.

As for standard SEIR-like models, we assumed that recovered people are immune and cannot be reinfected. It has been shown that individuals who were infected with SARS-CoV-2 develop some level of immunity to the disease for a certain time [15] , but the duration is not yet clear. . These effects could contribute to challenge herd immunity [19] , contrasting the effect of age distribution. Conceptual models [20] have been developed to investigate the interplay between naturally achieved individual immunity, immunity by vaccination and waning immunity, but much still need to be done with more supporting data. Finally, 640 the evolving impact of new variants -e.g. escaping antibodies [65] witnessed a major surge in cases in early 2021 [51] leave open the question if it will be possible to reach herd immunity against COVID-19 in reality.

Our comprehensive model describes the past epidemic dynamics and make reasonable projections. Despite some modelling assumptions, its basic structure 

The authors declare no competing interest. 

In this Appendix we illustrate the model, the considered data from Luxembourg, Austria and Sweden, a computational approach to estimate herd immunity and the procedures to provide an estimate of the parameters and their 705 uncertainties.

In this study, we developed a mathematical model of the transmission of COVID-19 within a population, building upon the standard SEIR model [23] .

Our extension of the SEIR model is described by Fig. 1 in the main text. The We assume conservation of the total population N (people can die, thus entering the dedicated compartments, but there is no removal of individuals from the system, and we neglect birth), such that for each country:

where the variables have been normalized by N to represent the fraction of the 740 total population being in the corresponding state. The dynamics of our model is described by the following system of ordinary differential equations:

We initialise every simulation with the initial conditions detailed in Tab. A.1.

For any simulation in this work (except those involving vaccination, see Appendix D) to numerically solve the set of ordinary differential equations we 745 employ the python (version 3.6.1) solver odeint from the package scipy (version 1.5.2), which uses the LSODA method for numerical integration.

Value at fraction of people t = 0 days

Recovering at Home (Detected) 0 D I,hos (t) Dead in hospitals (Detected) 0 D I,hom (t) Dead at home (Detected) 0

Recovered (Undetected) 0 

The parameters of the model and their interpretation are detailed in Tab. B.2.

The parameters can be divided in three categories, based on what type of phys-750 ical quantity they describe: rates, probabilities and social interaction.

When individuals can move from one compartment to one of two different compartments, the probability p i controls which fraction of people will go to one compartment, the remaining fraction 1 − p i going to the other. Their value is bounded between 0 and 1. The parameters p i are indexed with i = 1, . . . , 9.

The parameters α, β and τ i represent rates. The parameters τ i are indexed

Units ρ n social interaction (n = 0, 1, . . . , N ) adim.

β average contact rate

probability of ICU → AICU adim. p 5 probability of Hl → R II adim. p 6 probability of AICU → R II adim. p 7 probability of N I → R II adim. p 9 probability of N II → R A adim. To obtain R eff (t) from the current model we used the next generation matrix method [32, 67, 68] . From the next generation matrix, we find its eigenvalues R 0 and 0. In our case, R 0 is given by:

From R 0 , we can deduce R eff (t), given by

By substituting the values of the parameters for each country and scenario, we obtain the R eff (t) curves depicted in Fig. 3 model. We thus employ these computationally obtained ones, both because they account for any additional model complexity and in order to provide a more conservative estimate of when herd immunity might be reached.

We consider three different countries: Luxembourg, Austria and Sweden.

The model structure described above is maintained unchanged across the three countries. For consistency, we change the value of the total country population N and the parameter values so that the model fits the data of the corresponding country. We use data of total detected cases, hospitalized people, people in ICUs and dead people. We gathered these data from https: According to the public data mentioned above, the first positive case was detected in Luxembourg on February 29, 2020. Considering the lag between 870 being susceptible, being exposed and being detected, we initialize the model at its initial conditions reported in Tab Data about the COVID-19 prevalence in the population were obtained from the Con-Vince study [37] .

Each country in this study is modelled as a closed system, which might be Our model was used to regularly monitor the progression of the epidemic in Luxembourg and to produce short-and mid-term projections during the crisis.

It aimed to promptly deliver preliminary results and then increasingly more refined results and projections as available data increased over time. Hence, some of our parameters have been updated multiple times throughout the course 885 of the crisis, to incorporate new knowledge. In this manuscript, our model is reporter in its state in December 2020, but it has been, overall, a continuously evolving tool.

We obtained the dates at which major changes in policy took place in Austria According to the data mentioned above, the first positive case was detected in Austria on February 26, 2020. Considering the lag between being susceptible, being exposed and being detected, we initialize the model at its initial conditions reported in Tab egswe.org/en/data--results/covid-19-in-swedish-intensive-care/, https://c19.se (last accessed on 15/12/2020). They are displayed in Fig. 2 in main text, where we also report their 7-days moving average.

Swedish policy has been analysed e.g. in [34, 53, 69] . While the very first 920 case detected was on 31st January, no other case was detected until February 26.

It is likely that the first case was isolated and did not infect others, otherwise most likely a second case would have been detected earlier; in addition, the first case was reported from a woman who had traveled to Wuhan and was isolated upon detection. On the other hand, following the second detected case 925 on February 26, 9 more cases were detected in the next 2 days. To account for potential further lag in the uncertain starting time of the epidemic in Sweden, we initialise the model at its initial conditions reported in Tab Appendix G. To fit Sweden, the model needs time-dependent probabilities of detection and hospitalisation, unlike for Luxembourg or Austria

Extending our model to Sweden is to gain insight on a country which applied different policies than Luxembourg and Austria (which adopted similar policies).

To fit Swedish data with the same model structure as the other countries, it was not sufficient to consider a different set of parameter values. Instead, it was necessary to introduce time-dependent probabilities of being detected p 1Swe (t) and of being hospitalized p 2Swe (t), within an epidemic wave.

The parameter p 1 corresponds to the probability of an infected individual 940 being detected. To obtain an estimate of this parameter for Sweden, we considered prevalence data estimated weekly through antibody test for 8 consecutive weeks between mid April and mid June 2020, obtained from [38, 39] and shown in Fig. G.2 panel A. The prevalence went from about 4% to 6%, growing over the course of these two months, likely resulting from more infections. Due to 945 the large error bars, multiple functional forms could be considered a reasonable fit, so we chose the simplest linear fit.

Prevalence represents the total percentage of the country's population that is estimated to have contracted the virus, including detected and undetected individuals. We obtain an estimate of p 1Swe (t) as the ratio between the mea-950 sured detected cases and the total cases estimated from the prevalence. We This is between approximately 50% and 100% during March and April, as can be seen in both panels C and D, meaning that, during the early weeks/months of the epidemic, Sweden mostly detected those people that required hospital 975 treatment. This clearly changed in May and June, likely due to the change in testing strategy ordered by the government on May the 3rd [54] . As observed in [53] , the peak recorded end of June reflects an extension of the testing strategy to everyone with COVID-19 symptoms and to contact tracing. 

A key parameter for each country is the probability of being detected if infected, which has been derived from prevalence studies. For Luxembourg we consider this probability to be p 1 = 0.31 in the first wave thanks to the Con-Vince study [37] , and we assume it to be p ′ 1 = 0.4 for the second and third wave based on internal communication. These numbers correspond to values for total 1055 cases over detected cases of respectively 1/0.31=3.2 and 1/0.4=2.5, which are close to the value 2.3 reported as an approximated estimate for several countries by [40] . For Austria, p 1 ≈ 0.41 has been as well derived from prevalence data https://www.sora.at/nc/news-presse/news/news-einzelansicht/n ews/covid-19-praevalenz-1006.html (last accessed on 15/12/2020). For 1060 Sweden, we describe how we obtain p 1,Swe (t) and p 2,Swe (t) in Appendix G. This estimate is also based on the prevalence data from [38, 39] The parameter sets obtained by manual calibration are used in the manuscript to illustrate a number of qualitative and quantitative results. Nevertheless, the next question naturally arising is "how unique is each of these parameter sets, 1070 given the available data?". We thus want to investigate to what extent the available data constrain the parameters of the model, and to which extent these parameter values can change, i.e. to quantify the uncertainties in the estimation of these parameters, given the data. A Bayesian framework provides a natural perspective to explore this uncertainty. For this purpose, we apply Bayesian In-1075 ference, and in particular Markov Chain Monte Carlo (MCMC) methods to I) quantify the uncertainty (via credible intervals) of the estimates of each parameter given the data, and to II) assess uncertainties on combinations of parameters (credible regions), often better identifiable than the corresponding individual parameters. In order to apply Bayesian inference and MCMC methods, we employ 1080 the dedicated python library pymcmcstat [71] , version 1.9.0.

To perform Bayesian inference by MCMC, we need to construct a likelihood function of parameter values given the available data and to provide prior probability distributions for each parameter, which allows us to incorporate our prior 1085 knowledge. The vector of parameters, which will be specific for each country and wave, is here indicated as τ .

The pymcmcstat package employs for the Likelihood L (τ |data) function the sum of square residuals (SSR), such that the minimum of the SSR corresponds to the maximum of the Likelihood. This choice of the likelihood function corre-1090 sponds to assuming that deviations of data from the model are due to Gaussian errors, which is the simplest assumption to make without additional knowledge of the potential sources of errors.

The SSR for Luxembourg is:

where τ is the array of parameters, t i = T 0 , T 0 + 1, . . . , T f − 1, T f indicates the number of days from the beginning of the epidemic (assumed for that country),

T 0 and T f are respectively the first and last day of the wave under investigation (1st wave, 2nd wave or, for Luxembourg, 3rd wave), C is the cumulative total number of detected cases, H is the number of people in hospital, ICU is the number of people in ICU, D hosp and D home are respectively the number of people dead in hospital (including ICU) or outside hospital (D home includes also 1100 nursing houses). The same SSR was employed for Austria and Sweden (with the corresponding data and model variables), except that the two compartments for deaths were merged into one compartment due to lack of more fine-grained data.

The quantities in Eq. I.1 derived from the model, omitting the dependencies on time and parameters for ease of notation, in terms of the model variables The social interaction parameter ρ n ranges from 0 to 1. Each rate parameter ranges from 0 days −1 to 1 days −1 , except for beta that ranges from 0 days −1 1120 to 2 days −1 . Each probability parameter is from 0 to 0.5 or 0.5 to 1 depending what the probability represents. We opt for these somewhat reduced parameter space rather than the full interval from 0 to 1 because, without loss of generality To increase the speed of our sampling, we run 8 chains in parallel. Each chain is initialized at random initial conditions extracted from the flat prior 1145 distribution for each parameter. The multiple chains will also be useful to assess convergence of the chains (see next section). Each chain is run for 500000

iterations to ensure chain convergence (measured by the method described in the next sections). The first half of each chain is automatically discarded as burn-in (default settings of the package), while the second half is employed to 1150 determine the posterior probability distributions.

We did not employ the thinning of chains (only considering one sample every several) as it is not usually appropriate when the goal is precision of estimates from an MCMC sample [72] . Nevertheless, thinning can be useful 1155 for other reasons, such as memory or time constraints in post-chain processing.

It was thus used to generate the figures with estimates of the posteriors, e.g. 100th sample. Rather than thinning, we monitored the convergence of the MCMC estimates by comparing the outputs of multiple independent chains [72] . 1160 We thus considered the variation among these independent chains to implement the Gelman-Rubin diagnostic [73, 74] . We nevertheless further used a more quantitative approach.

There are many diagnostics available for assessing chain convergence. As 1170 suggested by [72] , a robust approach is to use the Gelman-Rubin diagnostic [73, 74] , which requires several sets of chains for comparison. The Gelman-Rubin approach essentially performs an analysis of the variances within each chain set and between each chain set. The same diagnostic was used for the same purpose in the framework of MCMC convergence in modelling COVID- 1175 19 in e.g. [42, 43] . The Gelman-Rubin diagnostics for the full chains returns values of R, the so-called "Potential Scale Reduction Factor (PSRF)", that are extremely close to 1 for most parameters, which indicates that the chains have converged [73, 74] . Posteriors are indicated by their 50% (blue) and 90% (cyan) credible intervals, and are usually considerably narrower than the assumed flat prior distributions (from Appendix I.2). Nevertheless, this is not the case for some parameters, for which the posteriors are almost flat and as wide as the priors.

This means that some parameters are not well identified by the available data and model structure. there is not a unique combination of parameters that allows a good fit of the 1245 model to the data, but many of them.

Moreover, certain combinations (e.g. ratios) of parameters are better constrained than the individual parameters. Consider e.g. the parameters α and β, which come from the standard SEIR model. 

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and coronavirus disease 19 (COVID-1275 19) -anatomic pathology perspective on current knowledge

How simulation modelling can help reduce the impact of COVID-19

Forecasting COVID-19-Associated Hospitalizations under Different Levels of Social Distancing in Lombardy and Emilia-Romagna, Northern Italy: Results from an Extended SEIR Com-1285 partmental Model

COVID-19 healthcare demand and mortality in Sweden in response to nonpharmaceutical mitigation and suppression scenarios

The contribution of asymptomatic SARS-CoV-2 infections to transmission on the diamond princess cruise ship

A mechanistic and data-driven reconstruction of the time-varying reproduction number: Application to the COVID-19 epidemic

Spread and dynamics of the COVID-19 epidemic in Italy: Effects of emergency containment measures

A novel covid-19 epidemiological model with explicit susceptible and asymptomatic 1305 isolation compartments reveals unexpected consequences of timing social distancing

Dynamical SPQEIR 1310 model assesses the effectiveness of non-pharmaceutical interventions against COVID-19 epidemic outbreaks

Effectiveness of non-pharmaceutical interventions to contain COVID-19: a case study of the 2020 spring pan-1315 demic wave in New York City

Modelling and predicting the effect of social distancing and travel restrictions on COVID-19 spreading

COVID-19 Crisis Management in Luxembourg: Insights from an Epidemionomic Approach, Luxembourg Institute of Socio-Economic Research (LISER) Working Paper Series 2020-08 (2020) Available at SSRN. 1325 doi

Vaccination and herd immunity: What more do we know?

COVID-19 herd immunity: where are we?

SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates

Transmission dynamics reveal the impracticality of 1335

COVID-19 herd immunity strategies

The use of mathematical models in epidemiological study of infectious diseases and in the design of mass immunization programmes

The Interaction of Natural and Vaccine-Induced Immunity with Social Distancing Predicts the Evolution of the COVID-19 Pandemic

Challenges in cre-1345 ating herd immunity to SARS-CoV-2 infection by mass vaccination

Trajectory of individual immunity and vaccination required for SARS-CoV-2 community immunity: 1350 a conceptual investigation

Joint impacts of media, vaccination and treatment on an epidemic Filippov model with application to COVID-19

Modelling optimal vaccination strategy for SARS-CoV-2 in the UK

A contribution to the 1360 mathematical theory of epidemics

Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2)

Agent-Based Modeling in Public Health: Current Applications and Future Directions

Estimating the impact of interventions against COVID-19: from lockdown to vaccination, medRxiv

Impact of vaccination and non-pharmaceutical interventions 1375 on SARS-CoV-2 dynamics in Switzerland, medRxiv

Modelling transmission and control of the COVID-19 pandemic in Australia

Superspreading events in the transmission dynamics of SARS-CoV-2: Opportunities for interventions and control

Age-structured epidemiology models and expressions for 1385 r 0

The discrete age-structured seit model with application to tuberculosis transmission in china

The construction of next-generation matrices for compartmental epidemic models

A mathematical model reveals the influence of population heterogeneity on herd immunity to SARS-CoV-2

COVID-19 length of hospital stay: A systematic review and data synthesis

The reproductive number of COVID-19 is higher compared to SARS coronavirus

Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating 1405 in Wuhan, China: a modelling study

Prevalence of SARS-CoV-2 infection in the Luxembourgish population: the CON-VINCE study., medRxiv

Påvisning av antikroppar efter genomgången covid-1415 19 i blodprov frånöppenvården

Påvisning av antikroppar efter genomgången covid-1420 19 hos blodgivare

Estimating the unde-1425 tected infections in the covid-19 outbreak by harnessing capture-recapture methods

The turning point and end of an expanding epidemic cannot be precisely forecast

Inferring change points in the spread of COVID-19 reveals the effectiveness of interventions

Estimating the impact of mobility patterns on COVID-19 infection rates in 11 European countries

Why is it difficult to accurately predict the covid-19 epidemic?

Model based estimation of the sars-cov-2 immunization level in austria and consequences for herd immunity effects

Monitoring transmissibility and mortality of covid-19 in europe

Estimating the reproductive number r0 of sars-cov-2 in the united states and eight euro-1450 pean countries and implications for vaccination

Estimating the basic reproduction number for covid-19 in western europe

Three-quarters attack rate of sars-cov-2 in the brazilian amazon during a largely unmitigated epidemic

Vaccination strategies based on feedback control techniques for a general seir-epidemic model

Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence

Effects of social distancing and isolation on epidemic spreading modeled via dynamical density functional theory

2020) 598 -612, the COVID-19 pandemic: Global health policy and technology responses in the making

The first eight months of Sweden COVID-19 strategy and the key actions and actors that were involved

Optimising social mixing strategies achieving COVID-19 herd immunity while minimising mortality in six European 1490 countries, medRxiv

Model-informed COVID-19 vaccine prioritization strategies by age and serostatus, medRxiv

Modelling of COVID-19 vaccination strategies and herd immunity

Targeted COVID-19 Vaccination (TAV-COVID) Considering Limited Vaccination Capacities -An Agent-Based Modeling Evaluation

Genomic evidence for reinfection with SARS-CoV-2: a case study

Understanding the outcomes of COVID-19-does the current model of an acute respiratory infection really fit?

mRNA Covid-19 Vaccine

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

Monitor for COVID-19 vaccine resistance evolution during clinical trials

Prospective mapping of viral mutations 1540 that escape antibodies used to treat COVID-19

Densely sampled viral trajectories suggest longer duration of acute infection with b.1.1.7 variant relative to non-b.1.1.7 sars-cov-2

Reproduction numbers of infectious disease models

An introduction to compartmental modeling 1550 for the budding infectious disease modeler

Characteristics and outcomes of patients with COVID-19 ad-1555 mitted to ICU in a tertiary hospital in

Utvecklingenöver tid, nyinskrivningar, avlidna och smittade på särskilt boende

pymcmcstat: a python package for bayesian inference using Delayed Rejection Adaptive Metropolis

On thinning of chains in MCMC

Inference from iterative simulation using multiple sequences

General Methods for Monitoring

Iterative Simulations

Bayesian inference of COVID-19 spreading rates in South Africa

considered, e.g. 19 for the 1st wave of Luxembourg. When we are interested